Merus NV
Change company Symbol lookup
Select an option...
MRUS Merus NV
WMT WALMART STORES INC
SLROF Stellar Resources Ltd
NTG Tortoise MLP Fund
LMT Lockheed Martin Corp
MO Altria Group Inc
AGN Allergan plc
ACN Accenture PLC
ABT Abbott Laboratories
ABBV AbbVie Inc
Go

Health Care : Biotechnology | Small Cap Growth
Based in NetherlandsCompany profile

Merus NV is a biotechnology company based in the Netherlands. The Company develops differentiating therapeutics for cancer patients. The product programs in the Merus pipeline are based on the Biclonics format. Its products inlcude, among others, MCLA-134 that is designed to bind to a combination of two immunomodulatory targets expressed by T cells, as wellas MCLA-145 that is designed to bind to a tumor-associated target with an immunomodulatory target involved in checkpoint inhibition.

Closing Price
$17.82
Day's Change
-0.18 (-1.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
18.15
Day's Low
17.76
Volume
(Heavy Day)
Volume:
54,888

10-day average volume:
26,242
54,888

Unable to locate that news article. Back to news results

Earnings Calendar and Events Data provided by |Terms of Use| © 2018 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2018. All rights reserved.